Tas2r105 functions as a "generalist" receptor, activated by >30% of tested bitter compounds . Key agonists include:
Discrepancies in agonist profiles between studies (e.g., cycloheximide selectivity vs. broad tuning) are attributed to differences in heterologous expression systems (Gα15 vs. Gα16gust44) .
Lingual Function: CRISPR-edited Tas2r105 knockout mice show abolished responses to cycloheximide, denatonium, and quinine .
Gut Immunity:
HEK293 Cells: Used for calcium imaging and cAMP assays to study receptor activation .
Knockout Mice: Highlight roles in taste perception (cycloheximide avoidance) and gut inflammation .
Taste Buds: Couples with Gα-gustducin to trigger PLCβ2-dependent Ca²⁺ signaling .
Immune Modulation: In the gut, Tas2r105 deletion increases TNF-α levels and macrophage infiltration while reducing T lymphocytes .
Key Metabolites: LPE (anti-inflammatory) and adenosine (immune regulation) are reduced in Tas2r105 KO mice .
Microbial Shifts: Enrichment of Clostridium and Bacteroides acidifaciens correlates with colitis severity .
Tas2r105 is a bitter taste receptor belonging to the type 2 taste receptors (T2Rs) family, which are members of the G-protein-coupled receptors (GPCRs) superfamily. This receptor plays a crucial role in the detection and avoidance of potentially harmful bitter compounds. Functionally, Tas2r105 has been characterized as a generalist receptor with an exceptionally broad agonist profile, responding to approximately 35% of tested bitter compounds in comprehensive screening studies .
The primary function of Tas2r105 is to mediate the recognition of bitter toxins, enabling animals to avoid potentially harmful substances. Research has demonstrated that Tas2r105 is particularly important for the detection of cycloheximide, as evidenced by studies with Tas2r105 knockout mice that show decreased avoidance responses to this compound . Beyond its role in taste perception, emerging evidence suggests Tas2r105 may serve important physiological functions in extraoral tissues, potentially contributing to immune and digestive responses .
Particularly notable is the expression of Tas2r105 in the gastrointestinal tract, specifically in the small intestinal villus and crypts . This extraoral expression suggests broader physiological roles beyond taste perception, potentially including immune surveillance, regulation of digestive processes, or detection of bacterial metabolites. The relative expression levels of Tas2r105 compared to other bitter taste receptors vary across tissues, with some studies showing moderately high expression in taste papillae compared to certain other Tas2r genes .
Tas2r105 exhibits one of the broadest agonist profiles among mouse bitter taste receptors, responding to 45 different bitter substances (35% of tested compounds) in comprehensive screening studies . Key agonists include:
Cycloheximide - Tas2r105 shows particular sensitivity to this compound, with studies confirming its crucial role in cycloheximide detection
N-acyl homoserine lactones - Compounds involved in bacterial quorum sensing that exclusively activate Tas2r105
Denatonium benzoate - A broadly detected bitter compound that activates Tas2r105
Quinine dihydrochloride - Activates Tas2r105 at threshold concentrations between 3.0-10 μM
PROP (propylthiouracil) - Activates multiple mouse Tas2rs including Tas2r105
Yohimbine - Detected by Tas2r105 at a threshold concentration of approximately 0.3 mM
Saccharin - Activates Tas2r105 at a threshold concentration of 1.0 mM
The potency and efficacy of these compounds vary considerably. For instance, concentration-response analyses reveal that Tas2r105 detects quinine at relatively low concentrations (3-10 μM), while higher concentrations of saccharin (1.0 mM) are required for activation .
Tas2r105, like other bitter taste receptors, utilizes the canonical taste signaling pathway involving several key components. When a bitter ligand binds to Tas2r105, the receptor undergoes conformational changes that activate associated G-proteins, particularly gustducin. The activated G-protein then triggers the following signaling cascade:
Activation of phospholipase C (PLC) β2, which hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to produce inositol triphosphate (IP3) and diacylglycerol (DAG)
IP3 binds to IP3 receptors on the endoplasmic reticulum, triggering release of Ca²⁺ from intracellular stores
Increased intracellular Ca²⁺ activates the transient receptor potential channel M5 (TRPM5)
TRPM5 activation leads to cation influx, resulting in membrane depolarization
Membrane depolarization stimulates the release of neurotransmitters such as ATP and acetylcholine
This signaling pathway has been demonstrated through studies using heterologous expression systems with different G-protein subunits. Research indicates that Tas2r105 responses are more robust when expressed in cells with Gα16gust44 compared to cells expressing only Gα15, suggesting important considerations for experimental design when studying this receptor .
The generation of Tas2r105 knockout models has been successfully accomplished using CRISPR/Cas9 gene-editing techniques. Based on published methodologies, the following protocol has proven effective:
Design of sgRNAs targeting the Tas2r105 coding region, with careful consideration of potential off-target effects. Multiple sgRNAs may be used to target different regions of the gene
Microinjection of a mixture containing Cas9 and sgRNA mRNAs into the cytoplasm of mouse zygotes
Screening of founder mice for genetic mutations at target sites using T7 Endonuclease 1 (T7EN1) assays
Confirmation of mutations by DNA sequencing to identify frameshift mutations that disrupt protein function
Breeding of heterozygous mice to establish homozygous knockout lines
For validation of knockout models, a multi-faceted approach is recommended:
Molecular validation:
Functional validation:
Specificity controls:
Heterologous expression of Tas2r105 in cell lines provides a powerful approach for characterizing receptor function. Based on published methodologies, the following protocol has proven effective:
Expression system selection:
Functional assay optimization:
Calcium imaging using fluorescent calcium indicators (e.g., Fluo-4) provides sensitive detection of receptor activation
Plate-based fluorometric assays enable high-throughput screening of potential ligands
Response normalization to positive controls (e.g., ATP or ionomycin) improves data reliability
Agonist characterization:
Important considerations:
Cell surface expression of bitter taste receptors can be challenging; inclusion of export sequences may improve trafficking
Receptor responses may be influenced by the specific G-protein coupling; systematic comparison of different G-proteins is recommended
Vehicle controls and mock-transfected cells are essential for distinguishing specific receptor-mediated responses from non-specific effects
The extraoral expression of Tas2r105, particularly in intestinal tissues, suggests physiological functions beyond taste perception . Current evidence points to several potential roles:
Detection of bacterial metabolites and quorum sensing molecules:
Regulation of innate immune responses:
To effectively study these extraoral functions, several methodologies are recommended:
Tissue-specific expression analysis:
Functional analysis:
Ex vivo calcium imaging of isolated cells or tissue explants from extraoral sites
Organoid cultures from intestinal tissues to study Tas2r105 function in a physiologically relevant system
Cell type-specific knockout models using conditional Cre-loxP systems to selectively delete Tas2r105 in extraoral tissues while preserving gustatory function
Physiological readouts:
Comparative analysis of Tas2r105 with human bitter taste receptors reveals important species-specific differences in receptor function and agonist profiles:
These comparative analyses provide valuable insights into the evolution of bitter taste perception and can guide the selection of appropriate animal models for studying specific aspects of bitter taste biology.
Expressing and purifying GPCRs, including Tas2r105, for structural studies presents numerous challenges that require specialized approaches:
Expression challenges:
Purification challenges:
Maintaining receptor stability in detergent solutions during extraction from membranes
Preserving native conformation and ligand-binding properties throughout purification
Achieving sufficient purity and homogeneity for crystallization or cryo-EM studies
Recommended strategies based on GPCR structural biology approaches:
Fusion protein approaches (e.g., T4 lysozyme or BRIL insertions) to enhance expression and crystallization properties
Thermostabilizing mutations identified through alanine scanning or directed evolution
Nanobody or antibody fragment co-crystallization to stabilize specific conformations
Lipid cubic phase crystallization to maintain a membrane-like environment
Expression screening in multiple systems (bacterial, yeast, insect, mammalian) to identify optimal conditions
Detergent screening to identify conditions that maintain receptor stability and function
Validation of purified receptor:
Ligand binding assays to confirm retention of native binding properties
Thermal stability assays (e.g., CPM or differential scanning fluorimetry) to assess protein stability
Size-exclusion chromatography and multi-angle light scattering to evaluate monodispersity
While no published structures of Tas2r105 are available based on the search results, these approaches represent the current state-of-the-art for GPCR structural biology and would be applicable to Tas2r105 structural studies.
Differentiating between the functions of Tas2r105 and other bitter taste receptors with overlapping agonist profiles requires a multi-faceted approach. The following methodologies have proven effective:
Genetic approaches:
Pharmacological approaches:
In vitro discrimination techniques:
Data analysis approaches:
The table below compares agonist profiles for Tas2r105 and selected other bitter taste receptors based on available data:
| Compound | Tas2r105 | Tas2r121 | Tas2r135 | Tas2r144 | Other Tas2rs |
|---|---|---|---|---|---|
| Cycloheximide | ++ | - | - | - | - |
| N-acyl homoserine lactones | ++ | - | - | - | - |
| Quinine | + (3-10 μM) | - | - | + | 5 others |
| Denatonium benzoate | + | - | - | + | 3 others |
| PROP | + | - | - | - | 5 others |
| Saccharin | + (1.0 mM) | - | + (0.1 mM) | + (10 mM) | 1 other |
| Yohimbine | + (0.3 mM) | - | - | - | 3 others |
Note: ++ indicates high selectivity; + indicates activation with threshold concentration in parentheses where available; - indicates no activation
Detecting Tas2r105 expression, particularly in extraoral tissues where expression levels may be low, requires sensitive and specific methodologies. Based on current research approaches, the following methods are recommended:
Transcript detection methods:
Quantitative real-time PCR (qRT-PCR) with carefully designed primers spanning exon junctions to ensure specificity
Digital PCR for absolute quantification of low-abundance transcripts
RNA-Seq and single-cell RNA-Seq for comprehensive transcriptome analysis and cellular localization
In situ hybridization with RNAscope or similar high-sensitivity techniques for spatial localization within tissues
Reverse transcription droplet digital PCR (RT-ddPCR) for absolute quantification of low-abundance transcripts
Protein detection methods:
Functional detection approaches:
Critical considerations:
Inclusion of appropriate positive controls (e.g., taste papillae) and negative controls
Validation with multiple independent methods to confirm expression
Use of Tas2r105 knockout tissues as specificity controls for antibody-based methods
Careful primer and probe design to avoid cross-reactivity with other Tas2r family members
The sensitivity and specificity of these methods vary considerably. Based on published studies, qRT-PCR combined with in situ hybridization provides a robust approach for detecting Tas2r105 expression, with good correlation between these methods observed in taste tissues .
Research on Tas2r105 expression and function in extraoral tissues has significant implications for understanding broader chemosensory mechanisms beyond taste perception. Key contributions include:
Gastrointestinal chemosensing:
Host-microbe interactions:
Innate immunity:
Translational applications:
Future research directions should focus on:
Tissue-specific conditional knockout models to delineate the physiological roles of Tas2r105 in different systems
Identification of endogenous agonists that may activate Tas2r105 in extraoral contexts
Characterization of downstream signaling pathways that may differ from canonical taste signaling in other tissues
Investigation of potential interactions between Tas2r105 and other chemosensory or immune receptors
Several experimental models have proven valuable for investigating Tas2r105 function in vivo, each with specific advantages for addressing different research questions:
Genetically modified mouse models:
CRISPR/Cas9-generated Tas2r105 knockout mice enable direct assessment of receptor function in various physiological contexts
Cluster knockouts targeting multiple Tas2r genes (e.g., Tas2r106/Tas2r104/Tas2r105/Tas2r114) help address functional redundancy among related receptors
Conditional knockout models using tissue-specific Cre drivers allow investigation of Tas2r105 function in specific cell populations
Reporter knockin lines expressing fluorescent proteins under Tas2r105 promoter control facilitate identification and isolation of Tas2r105-expressing cells
Behavioral assays:
Two-bottle preference tests provide a robust measure of taste perception and avoidance behaviors
Brief-access lick tests offer more refined analysis of immediate taste responses
Conditioned taste aversion paradigms can assess the aversive properties of Tas2r105 agonists
Operant conditioning approaches to quantify motivation and discrimination capabilities
Ex vivo tissue preparations:
In vivo physiological measurements:
Gustatory nerve recordings to assess taste signaling at the peripheral nervous system level
Intravital microscopy of labeled Tas2r105-expressing cells to monitor responses in living tissues
Metabolic phenotyping to assess potential roles in energy homeostasis
Immune challenge models to investigate contributions to host defense mechanisms
Each model system has specific strengths and limitations. Integration of multiple approaches is recommended for comprehensive characterization of Tas2r105 function across different physiological contexts.